BioCentury
ARTICLE | Company News

miRagen, University of Glasgow deal

March 11, 2013 7:00 AM UTC

The university granted miRagen exclusive rights to IP covering microRNA-145. The IP was discovered under a deal between the university, biotech and University of Cambridge (Cambridge, U.K.) to devel...